Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells

Cell Cycle

Volumn 7, Issue 15, 2008, Pages 2392-2400

  Mannava, Sudha ^a,b,d   Grachtchouk, Vladimir ^a,b,d   Wheeler, Linda J ^a,e   Im, Michael ^a,c   Zhuang, Dazhong ^a,b,d   Slavina, Elena G ^a,f   Mathews, Christopher K ^a,e   Shewach, Donna S ^a,c   Nikiforov, Mikhail A ^a,d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e OREGON STATE UNIVERSITY   (United States)

^f N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

C MYC; Melanoma; Nucleotide metabolism

Indexed keywords

COMPLEMENTARY DNA; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE 2; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE 2; SHORT HAIRPIN RNA; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F1;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DEPLETION; ENZYME REPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; MOLECULAR INTERACTION; NUCLEOTIDE METABOLISM; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

LENTIVIRUS;

EID: 48849105341     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6390     Document Type: Article

References (39)

1. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6:635-5.
2. Nesbit CE, Tersak JM, Prochownik EV. Myc oncogenes and human neoplastic disease. Oncogene 1999; 18:3004-16.
3. Hermeking H. The MYC oncogene as a cancer drug target. Curr Cancer Drug Targets 2003; 3:163-75.
4. Arvanitis C, Felsher DW. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 2006; 16:313-7.
5. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol 2006; 16:253-4.
6. Eisenman RN. Deconstructing myc. Genes Dev 2001; 15:2023-30.
7. Nair SK, Burley SK. Structural aspects of interactions within the Myc/Max/Mad network. Curr Top Microbiol Immunol 2006; 302:123-44.
8. Lee LA, Dang CV. Myc target transcriptosomes. Curr Top Microbiol Immunol 2006; 302:145-68.
9. Kleine-Kohlbrecher D, Adhikary S, Eilers M. Mechanisms of transcriptional repression by Myc. Curr Top Microbiol Immunol 2006; 302:51-62.
10. Cole MD, Nikiforov MA. Transcriptional activation by the Myc oncoprotein. Curr Top Microbiol Immunol 2006; 302:33-50.
11. Basseres DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25:6817-30.
12. Laptenko O, Prives C.Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13:951-61.
13. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004; 4:562-68.
14. Cappellen D, Schlange T, Bauer M, Maurer F and Hynes MF. Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep 2007; 8:70-6.
15. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. Identification of CDK4 as a target of c-Myc. Proc Natl Acad Sci USA 2000; 97:2229-34.
16. Nikiforov MA, Chandriani S, O'Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM, Cole MD. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 2002; 22:5793-800.
17. Rothermund K, Rogulski K, Fernandes E, Whiting A, Sedivy J, Pu L, Prochownik EV. c-Myc-independent restoration of multiple phenotypes by two c-Myc target genes with overlapping functions. Cancer Research 2005; 65:2097-107.
18. Wang H, Mannava S, Grachtchouk V, Zhuang D, Soengas MS, Gudkov AV, Prochownik EV, Nikiforov MA. c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 2008; 27:1905-15.
19. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets 2003; http://genomebiology.com/2003/4/ 10/R69.
20. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet 1999; 21:220-4.
21. Pena A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ. Regulation of human ornithine decarboxylase expression by the c-Myc:Max protein complex. J Biol Chem 1993; 268:27277-85.
22. Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, Smith C, Nevins JR. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 2001; 8:105-13.
23. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol 1995; 15:2527-35.
24. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 1999; 18:5321-33.
25. Montfort WR, Weichsel A. Thymidylate synthase: structure, inhibition and strained conformations during catalysis. Pharmacol Ther 1997; 76:29-43.
26. Hedstrom L. IMP dehydrogenase: mechanism of action and inhibition. Curr Med Chem 1999; 6:545-60.
27. Becker MA. Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells. Prog Nucleic Acid Res Mol Biol 2001; 69:115-48.
28. Voeller DL, Rahman M, Zajac-Kaye M. Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells. Cell Cycle 2004; 3:1005-7.
29. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 1993; 13:5216-24.
30. Calascibetta A, Cabibi D, Martorana A, Sanguedolce G, Rausa L, Feo S, Dardanoni G, Sanguedolce R. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. Anticancer Research 2004; 24:3875-80.
31. Marcuello E, Altes A, del Rio E, Cesar A, Menoyo A, Baiget M. Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004; 112:733-37.
32. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997; 8:1039-48.
33. Martomo SA, Mathews CK. Effects of biological DNA precursor pool asymmetry upon accuracy of DNA replication in vitro. Mutat Res 2002; 499:197-211.
34. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 2002; 9:1031-44.
35. Ray S, Atkuri KR, Deb-Basu D, Adler AS, Chang HY, Herzenberg LA, Felsher DW. MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. Cancer Research 2006; 66:6598-605.
36. Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW Jr, Lowe SW, Soengas MS. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 2005; 65:6294-304.
37. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3.
38. Shewach DS. Quantitation of deoxyribonucleoside 5′-triphosphates by a sequential boronate and anion-exchange high-pressure liquid chromatographic procedure. Anal Biochem 1992; 1:178-82.
39. Song S, Wheeler LJ, Mathews CK. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 2003; 278:43893-6.